Department of Neuroscience, Section Medical Physiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Cellular Neurosciences, Max Delbrück Centre for Molecular Medicine, Berlin, Germany.
Brain Behav Immun. 2015 Aug;48:205-21. doi: 10.1016/j.bbi.2015.03.013. Epub 2015 Apr 2.
Microglia, the innate immune cells of the central nervous system (CNS), react to endotoxins like bacterial lipopolysaccharides (LPS) with a pronounced inflammatory response. To avoid excess damage to the CNS, the microglia inflammatory response needs to be tightly regulated. Here we report that a single LPS challenge results in a prolonged blunted pro-inflammatory response to a subsequent LPS stimulation, both in primary microglia cultures (100 ng/ml) and in vivo after intraperitoneal (0.25 and 1mg/kg) or intracerebroventricular (5 μg) LPS administration. Chromatin immunoprecipitation (ChIP) experiments with primary microglia and microglia acutely isolated from mice showed that LPS preconditioning was accompanied by a reduction in active histone modifications AcH3 and H3K4me3 in the promoters of the IL-1β and TNF-α genes. Furthermore, LPS preconditioning resulted in an increase in the amount of repressive histone modification H3K9me2 in the IL-1β promoter. ChIP and knock-down experiments showed that NF-κB subunit RelB was bound to the IL-1β promoter in preconditioned microglia and that RelB is required for the attenuated LPS response. In addition to a suppressed pro-inflammatory response, preconditioned primary microglia displayed enhanced phagocytic activity, increased outward potassium currents and nitric oxide production in response to a second LPS challenge. In vivo, a single i.p. LPS injection resulted in reduced performance in a spatial learning task 4 weeks later, indicating that a single inflammatory episode affected memory formation in these mice. Summarizing, we show that LPS-preconditioned microglia acquire an epigenetically regulated, immune-suppressed phenotype, possibly to prevent excessive damage to the central nervous system in case of recurrent (peripheral) inflammation.
小胶质细胞是中枢神经系统(CNS)的固有免疫细胞,对细菌脂多糖(LPS)等内毒素会产生明显的炎症反应。为了避免中枢神经系统受到过度损伤,小胶质细胞的炎症反应需要受到严格的调控。在这里,我们报告称,单次 LPS 刺激会导致后续 LPS 刺激时小胶质细胞的促炎反应明显减弱,这种现象不仅在原代小胶质细胞培养物(100ng/ml)中存在,而且在腹腔内(0.25 和 1mg/kg)或侧脑室(5μg)给予 LPS 后体内也存在。用原代小胶质细胞和从小鼠急性分离的小胶质细胞进行染色质免疫沉淀(ChIP)实验表明,LPS 预处理伴随着 IL-1β 和 TNF-α 基因启动子中活性组蛋白修饰 AcH3 和 H3K4me3 的减少。此外,LPS 预处理导致 IL-1β 启动子中抑制性组蛋白修饰 H3K9me2 的量增加。ChIP 和敲低实验表明,NF-κB 亚基 RelB 与预处理小胶质细胞中的 IL-1β 启动子结合,RelB 是减弱 LPS 反应所必需的。除了促炎反应受到抑制外,预处理的原代小胶质细胞在受到第二次 LPS 刺激时显示出增强的吞噬活性、增加的外向钾电流和一氧化氮产生。在体内,单次腹腔内 LPS 注射会导致 4 周后空间学习任务表现下降,表明单次炎症发作会影响这些小鼠的记忆形成。总之,我们表明 LPS 预处理的小胶质细胞获得了一种受表观遗传调控的免疫抑制表型,可能是为了防止中枢神经系统在反复(外周)炎症的情况下受到过度损伤。